Yale urology doctors and professors celebrate “No Shave November” by shaving their beards and mustaches to highlight the ...

He further noted that active surveillance is generally recommended for patients diagnosed with early-stage, low-grade ...

On International Men's Day, the Clinical Trials Arena team investigates three therapies being investigated in prostate cancer ...

The completion of enrollment of the SOLAR-RECUR trial is yet another significant milestone for Curium. Cu 64 PSMA I&T represents an important pillar in the development of our theranostic program for ...

Janux Therapeutics' innovative cancer treatment shows promise in reducing side effects and improving patient outcomes, but ...

He was prescribed hormone therapy to reduce testosterone levels and then 33 radiation applications spread over five ... said ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Overscreening and overtreatment of men with prostate cancer and limited life expectancy continue to be an ongoing issue in the era of active surveillance.

New London ― Dean Festa got lucky when he sought to make a change in his life insurance policy. His insurance agent told him ...

Discover a recent study that revealed that patients treated for prostate cancer, particularly with radiotherapy, have an ...

Research conducted at Beilinson Hospital shows two radiation sessions may match the effectiveness of five treatments, promising a reduced burden on patients.

After a comprehensive two-year follow-up, researchers found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality ...